Poster discussed by Ishann Sehgal, City of Hope - Friends of Cancer Research - Dr. Monty Pal served as a guide and advisory mentor.
Ishann Sehgal addresses the eligibility requirements for clinical trials involving renal cell carcinoma (RCC) in this video. He also covers the advancements that ASCO and FCR have made in the treatment of RCC.
According to Ishann, the qualifying standards for RCC clinical research have traditionally been quite stringent. This has the potential to restrict patient involvement and affect the findings of the study. Both the ASCO and the FCR have revised their qualifying requirements in order to accommodate a greater number of patients.